Biodesix, Inc. announced that it will release its fourth quarter and full-year 2025 financial results on February 26, 2026, after the market closes. The Louisville, Colorado-based company will also host a conference call and webcast at 4:30 p.m. Eastern Time on the same day to discuss its financial performance and general business updates.

Biodesix’s stock performance recently moved into a higher bracket, with its IBD Relative Strength Rating rising from 70 to 84. This upgrade means the company has topped a critical 80-plus threshold, signaling improved market traction.